79.48
0.37%
+0.29
After Hours:
79.32
-0.16
-0.20%
Medtronic Plc stock is currently priced at $79.48, with a 24-hour trading volume of 6.39M.
It has seen a +0.37% increased in the last 24 hours and a -5.50% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $78.97 pivot point. If it approaches the $79.52 resistance level, significant changes may occur.
Medtronic Plc Stock (MDT) Financials Data
Medtronic Plc (MDT) Revenue 2024
MDT reported a revenue (TTM) of $32.32 billion for the quarter ending January 31, 2024, a +5.03% rise year-over-year.
Medtronic Plc (MDT) Net Income 2024
MDT net income (TTM) was $4.20 billion for the quarter ending January 31, 2024, a +3.40% increase year-over-year.
Medtronic Plc (MDT) Cash Flow 2024
MDT recorded a free cash flow (TTM) of $4.93 billion for the quarter ending January 31, 2024, a +18.36% increase year-over-year.
Medtronic Plc (MDT) Earnings per Share 2024
MDT earnings per share (TTM) was $3.14 for the quarter ending January 31, 2024, a +3.29% growth year-over-year.
Medtronic Plc Stock (MDT) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Marinaro Michael | EVP & President, Surgical OU |
Apr 08 '24 |
Sale |
83.14 |
854 |
71,002 |
27,925 |
Salmon Sean | EVP & President Cardiovascular |
Feb 21 '24 |
Option Exercise |
69.07 |
30,695 |
2,120,121 |
78,984 |
Salmon Sean | EVP & President Cardiovascular |
Feb 21 '24 |
Sale |
85.13 |
30,695 |
2,613,055 |
48,289 |
Wall Brett A. | EVP & Pres Neuroscience |
Dec 19 '23 |
Sale |
82.17 |
4,997 |
410,603 |
28,910 |
Smith Gregory L | EVP Global Ops & Supply Chain |
Aug 23 '23 |
Sale |
83.84 |
10,000 |
838,400 |
46,723 |
Wall Brett A. | EVP & Pres Neuroscience |
Aug 14 '23 |
Sale |
83.38 |
1,000 |
83,380 |
33,573 |
Marinaro Michael | EVP & President, Surgical OU |
Aug 04 '23 |
Sale |
84.11 |
1,352 |
113,717 |
28,930 |
Wall Brett A. | EVP & Pres Neuroscience |
Jul 14 '23 |
Sale |
87.97 |
2,000 |
175,940 |
23,948 |
TEN HOEDT ROB | EVP and Pres. Global Regions |
Jul 10 '23 |
Option Exercise |
55.32 |
5,514 |
305,034 |
47,508 |
TEN HOEDT ROB | EVP and Pres. Global Regions |
Jul 10 '23 |
Sale |
86.58 |
5,514 |
477,420 |
43,802 |
Medtronic Plc Stock (MDT) Latest News
Here's Why You Should Retain Medtronic (MDT) Stock for Now
Zacks Investment Research
Medtronic Stock: Buy, Sell, or Hold?
The Motley Fool
The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic
Zacks Investment Research
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
Zacks Investment Research
Q1 Earnings Scorecard and Analyst Reports for Mastercard, Netflix & Coca-Cola
Zacks Investment Research
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
The Motley Fool
About Medtronic Plc
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation product; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; hardware instruments and mesh fixation device; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, colorectal surgeons, urogynecologists, interventional radiologists, and ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Cap:
|
Volume (24h):